Neo-MASCT Immunotherapy for Advanced NSCLC.
Condition(s):NSCLC Stage IVLast Updated:July 5, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):NSCLC Stage IVLast Updated:July 5, 2017Unknown status
Condition(s):Non Small Cell Lung CancerLast Updated:April 21, 2021Unknown status
Condition(s):Non-Small Cell Lung Cancer; EGFR Gene MutationLast Updated:October 24, 2023Active, not recruiting
Condition(s):EfficacyLast Updated:March 12, 2024Not yet recruiting
Condition(s):NSCLCLast Updated:January 26, 2022Not yet recruiting
Condition(s):NSCLCLast Updated:September 30, 2020Completed
Condition(s):Non-small Cell Lung Cancer; NSCLC; PD-1Last Updated:February 24, 2023Not yet recruiting
Condition(s):Advanced or Metastatic NSCLCLast Updated:February 27, 2023Completed
Condition(s):Non Small Cell Lung CancerLast Updated:January 1, 2010Unknown status
Condition(s):NSCLCLast Updated:March 11, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.